A detailed history of Ubs Group Ag transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ubs Group Ag holds 66,900 shares of TEVA stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,900
Previous 2,013,135 96.68%
Holding current value
$1.14 Million
Previous $32.7 Million 96.32%
% of portfolio
0.0%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $5.85 Million - $7.01 Million
-369,941 Reduced 18.38%
1,643,194 $29.6 Million
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $2.37 Million - $3.22 Million
-185,067 Reduced 8.42%
2,013,135 $32.7 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $13.8 Million - $18.7 Million
1,295,758 Added 143.58%
2,198,202 $31 Million
Q4 2023

Feb 09, 2024

SELL
$8.12 - $10.63 $3.49 Million - $4.57 Million
-429,968 Reduced 32.27%
902,444 $9.42 Million
Q3 2023

Nov 09, 2023

BUY
$7.48 - $10.7 $2.42 Million - $3.46 Million
323,262 Added 32.03%
1,332,412 $13.6 Million
Q2 2023

Aug 11, 2023

SELL
$7.2 - $9.47 $303,134 - $398,705
-42,102 Reduced 4.0%
1,009,150 $7.6 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $2.17 Million - $2.95 Million
-259,662 Reduced 19.81%
1,051,252 $9.3 Million
Q4 2022

Feb 08, 2023

SELL
$7.95 - $9.48 $407,652 - $486,105
-51,277 Reduced 3.76%
1,310,914 $12 Million
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $796,974 - $1.39 Million
-116,177 Reduced 7.86%
1,362,191 $11 Million
Q2 2022

Aug 10, 2022

SELL
$7.38 - $10.4 $3.32 Million - $4.68 Million
-450,356 Reduced 23.35%
1,478,368 $11.1 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $6.69 Million - $8.57 Million
-912,874 Reduced 32.13%
1,928,724 $18.1 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $9.84 Million - $12.7 Million
1,245,502 Added 78.03%
2,841,598 $22.8 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $2.22 Million - $2.7 Million
265,204 Added 19.93%
1,596,096 $15.5 Million
Q2 2021

Aug 13, 2021

SELL
$9.9 - $11.56 $1.3 Million - $1.51 Million
-131,023 Reduced 8.96%
1,330,892 $13.2 Million
Q1 2021

May 12, 2021

SELL
$10.34 - $12.81 $833,476 - $1.03 Million
-80,607 Reduced 5.23%
1,461,915 $16.9 Million
Q4 2020

Feb 11, 2021

BUY
$8.61 - $11.04 $2.42 Million - $3.1 Million
281,137 Added 22.29%
1,542,522 $14.9 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $3.14 Million - $4.66 Million
-366,927 Reduced 22.53%
1,261,385 $11.4 Million
Q2 2020

Jul 31, 2020

SELL
$8.12 - $13.12 $1.27 Million - $2.06 Million
-156,920 Reduced 8.79%
1,628,312 $20.1 Million
Q1 2020

May 01, 2020

SELL
$6.69 - $13.45 $430,769 - $866,045
-64,390 Reduced 3.48%
1,785,232 $16 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $3 Million - $4.92 Million
-459,106 Reduced 19.89%
1,849,622 $18.1 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $4.87 Million - $7.59 Million
790,970 Added 52.11%
2,308,728 $15.9 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $943,690 - $1.83 Million
-116,218 Reduced 7.11%
1,517,758 $14 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $1.78 Million - $2.29 Million
-114,506 Reduced 6.55%
1,633,976 $25.6 Million
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $6.47 Million - $10.6 Million
-443,330 Reduced 20.23%
1,748,482 $27 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $5.32 Million - $6.48 Million
-252,498 Reduced 10.33%
2,191,812 $47.2 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $14.2 Million - $21 Million
848,706 Added 53.19%
2,444,310 $59.4 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $5.1 Million - $6.75 Million
305,767 Added 23.71%
1,595,604 $27.3 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $5.14 Million - $8.74 Million
-457,640 Reduced 26.19%
1,289,837 $24.4 Million
Q3 2017

Nov 14, 2017

SELL
$15.41 - $32.17 $4.08 Million - $8.52 Million
-264,977 Reduced 13.17%
1,747,477 $30.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
131,020 Added 6.96%
2,012,454 $66.9 Million
Q1 2017

Nov 14, 2017

BUY
N/A
1,881,434
1,881,434 $60.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.